News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
PETERSON RICHARD D
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2022 |
4
| PETERSON RICHARD D (Director) has filed a Form 4 on UNIVERSAL INSURANCE HOLDINGS, INC.
Txns:
| Bought 1,075 shares
@ $9.305, valued at
$10k
|
|
06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/11/2019 |
4
| PETERSON RICHARD D (Director) has filed a Form 4 on UNIVERSAL INSURANCE HOLDINGS, INC.
Txns:
| Exercised 30,000 shares
@ $20.09, valued at
$602.7k
Paid exercise price by delivering 20,891 shares
@ $28.85, valued at
$602.7k
Exercised 30,000 options to buy
@ $20.09, valued at
$602.7k
|
|
03/18/2019 |
4
| PETERSON RICHARD D (Director) has filed a Form 4 on UNIVERSAL INSURANCE HOLDINGS, INC.
Txns:
| Granted 20,000 options to buy
@ $31.64, valued at
$632.8k
|
|
04/11/2018 |
4
| PETERSON RICHARD D (Director) has filed a Form 4 on UNIVERSAL INSURANCE HOLDINGS, INC.
Txns:
| Exercised 800 shares
@ $19.85, valued at
$15.9k
Paid exercise price by delivering 515 shares
@ $30.85, valued at
$15.9k
Exercised 800 options to buy
@ $19.85, valued at
$15.9k
|
|
08/01/2017 |
4
| PETERSON RICHARD D (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns:
| Bought 7,000 shares
@ $15, valued at
$105k
|
|
07/27/2017 |
4
| PETERSON RICHARD D (CFO) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns:
| Granted 8,518 options to buy
@ $15, valued at
$127.8k
|
|
07/26/2017 |
3
| PETERSON RICHARD D (CFO) has filed a Form 3 on Sienna Biopharmaceuticals, Inc. |
11/07/2016 |
4
| PETERSON RICHARD D (Director) has filed a Form 4 on UNIVERSAL INSURANCE HOLDINGS, INC.
Txns:
| Granted 20,000 options to buy
@ $19.85, valued at
$397k
|
|
09/20/2016 |
3
| PETERSON RICHARD D (CFO) has filed a Form 3 on Novan, Inc. |
06/16/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/13/2012 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Gifted 2,300 shares
@ $0 Disposed/sold 205,889 shares
@ $44, valued at
$9.1M
Disposed/sold 102 shares
@ $44, valued at
$4.5k
Disposed/sold 36,000 options to buy
@ $38.45, valued at
$1.4M
|
|
08/17/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/05/2012 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 1,467 shares
@ $38.23, valued at
$56.1k
|
|
03/09/2012 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 572 shares
@ $34.71, valued at
$19.9k
|
|
03/07/2012 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 1,414 shares
@ $35.01, valued at
$49.5k
|
|
03/05/2012 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 1,671 shares
@ $34.95, valued at
$58.4k
Paid exercise price by delivering 1,303 shares
@ $34.95, valued at
$45.5k
|
|
03/02/2012 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Granted 42,072 shares
@ $0 |
|
02/29/2012 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 5,169 shares
@ $33.81, valued at
$174.8k
|
|
05/17/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/06/2011 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 978 shares
@ $33.19, valued at
$32.5k
|
|
03/08/2011 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 744 shares
@ $31.24, valued at
$23.2k
Paid exercise price by delivering 426 shares
@ $30.76, valued at
$13.1k
|
|
02/09/2011 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 271 shares
@ $27.64, valued at
$7.5k
|
|
08/16/2010 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Sold 8,435 shares
@ $26.5, valued at
$223.5k
|
|
07/23/2010 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 263 shares
@ $24.63, valued at
$6.5k
|
|
05/17/2010 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Sold 22,010 shares
@ $25.2645, valued at
$556.1k
Sold 1,000 shares
@ $24.5185, valued at
$24.5k
Exercised 22,010 options to buy
@ $18.33, valued at
$403.4k
|
|
04/06/2010 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 407 shares
@ $25.02, valued at
$10.2k
|
|
03/09/2010 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 416 shares
@ $23.09, valued at
$9.6k
Paid exercise price by delivering 317 shares
@ $23.09, valued at
$7.3k
|
|
03/03/2010 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Granted 57,293 shares
@ $0 |
|
03/02/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/09/2010 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP
Txns:
| Paid exercise price by delivering 315 shares
@ $22.27, valued at
$7k
|
|
07/23/2009 |
4
| PETERSON RICHARD D (EVP, CFO & Corp Treasurer) has filed a Form 4 on MEDICIS PHARMACEUTICAL CORP |
|
|
|